Search filters

List of works by Wendy A Keitel

2492. Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients

scholarly article by Hana M El Sahly et al published November 2018 in Open Forum Infectious Diseases

A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults

scientific article

A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route

scientific article

Adjuvants for pandemic influenza vaccines.

scientific article

Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination

scientific article

Antibody quantity versus quality after influenza vaccination

scientific article published on October 2009

Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).

scientific article

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

scientific article published on 4 December 2015

Challenges Remain for Influenza Vaccination of Children

scientific article published on 28 August 2016

Clinical data on Fluarix: an inactivated split seasonal influenza vaccine

scientific article

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

scientific article published on July 2015

Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans

scientific article published on 14 July 2009

Direct Comparison of an Inactivated Subvirion Influenza A Virus Subtype H5N1 Vaccine Administered by the Intradermal and Intramuscular Routes ⬇️

scientific article published on August 13, 2012

Domain specificity of the human antibody response to Bacillus anthracis protective antigen

scientific article published on 2 June 2008

Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial.

scientific article

Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial

scientific article

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial

scientific article published on 25 December 2013

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial

scientific article published on October 2008

Effects of infection and disease with Mycobacterium tuberculosis on serum antibody to glucan and arabinomannan: two surface polysaccharides of this pathogen

scientific article

Efficacy of an acellular pertussis vaccine among adolescents and adults.

scientific article

Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy

scientific article published on 23 September 2003

Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults

scientific article

Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults

scientific article published in January 2002

Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine ⬇️

scientific article published on August 22, 2011

Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human

scientific article published on 24 April 2014

Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies

scientific article

Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed

scientific article published on 17 February 2009

Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses

scientific article published in December 2008

Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial

scientific article published on 24 January 2012

Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans

scientific article

Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study

scientific article published on 7 July 2004

Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women

scientific article

Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine

scientific article published on 02 June 2008

Increased antibodies against unfolded viral antigens in the elderly after influenza vaccination

scientific article published on July 2007

Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria

scientific article

Influenza A(H5N1) vaccines: are we better prepared for the next pandemic?

scientific article published on 24 October 2013

Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here?

scientific article

Intanza®: a new intradermal vaccine for seasonal influenza ⬇️

scientific article published on December 1, 2010

Multiple Epstein-Barr Virus Infections in Healthy Individuals ⬇️

scientific article published on June 1, 2003

Pandemic H5N1 influenza vaccine development: an update.

scientific article

Paratope diversity in the human antibody response to Bacillus anthracis protective antigen

scientific article

Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 Adjuvant

scientific article

Perspectives on human microbiome research ethics

scientific article

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

scientific article

Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy.

scientific article

Prenatal passive transfer of maternal immunity in Asian elephants (Elephas maximus).

scientific article

Preparing for a possible pandemic: influenza A/H5N1 vaccine development.

scientific article

Prevalence of Antibody to Bordetella pertussis Antigens in Serum Specimens Obtained from 1793 Adolescents and Adults

scientific article published in 2004

Progress in the Diagnosis, Prevention, and Treatment of Pertussis

scientific article published in June 2003

Progress toward the Development of a NEAT Protein Vaccine for Anthrax Disease

scientific article published on 19 September 2016

Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

scientific article published on 23 December 2017

Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines ⬇️

scientific article published on October 26, 2012

Rapid research response to the 2009 A(H1N1)pdm09 influenza pandemic (Revised).

scientific article

Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine

scientific article

Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: safety, immunogenicity, and protective efficacy

scientific article

Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.

scientific article

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

scientific article

Safety and immunogenicity of a candidate parvovirus B19 vaccine ⬇️

scientific article published on July 30, 2011

Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial

scientific article published on 27 February 2017

Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults

scientific article published on 03 July 2009

Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.

scientific article

Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults

scientific article

Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.

scientific article

Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons

article

Safety of zoster vaccine in elderly adults following documented herpes zoster

scientific article published on 30 April 2013

Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant

scientific article

The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters ⬇️

scientific article published on November 19, 2012

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial

scientific article

Vaccines for pandemic influenza: summary of recent clinical trials.

scientific article

Paulina is supported by:

About Paulina

Help